Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
002524 Guangzheng Eye Hospital Group
- 4.78
- +0.07+1.49%
Not Open Dec 11 15:00 CST
2.48BMarket Cap-113.81P/E (TTM)
4.81High4.69Low164.76KlotVolume4.71Open4.71Pre Close78.44MTurnover3.24%Turnover Ratio265.56P/E (Static)518.47MShares6.6052wk High9.09P/B2.43BFloat Cap2.9052wk Low5.18Limit Up508.30MShs Float18.85Historical High4.24Limit Down2.55%Amplitude2.66Historical Low--Dividend TTM4.76Avg Price83.91KlotAsk--Div YieldTTM100Lot Size80.22KlotBid
Guangzheng Eye Hospital Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.40%703.18M | 0.80%468.22M | 0.38%195.53M | 13.67%974.32M | 11.36%706.02M | 25.44%464.51M | -9.72%194.8M | -22.64%857.17M | -20.95%634.01M | -27.83%370.29M |
| Refunds of taxes and levies | 55.65%3.92M | 953.51%3.29M | 1,416.06%2.64M | -94.92%197.02K | -38.83%2.52M | -92.13%312.7K | -75.44%174.35K | 389.90%3.88M | 2,400.22%4.11M | --3.97M |
| Cash received relating to other operating activities | -35.72%27.19M | 8.18%17.78M | -14.82%2.57M | 3.71%42.98M | -20.10%42.3M | -63.39%16.43M | -92.79%3.02M | -18.78%41.44M | 248.33%52.93M | 350.61%44.89M |
| Cash inflows from operating activities | -2.20%734.28M | 1.67%489.29M | 1.39%200.75M | 12.74%1.02B | 8.65%750.83M | 14.82%481.26M | -23.35%197.99M | -22.19%902.49M | -15.46%691.06M | -19.86%419.15M |
| Goods services cash paid | -18.61%323.85M | -20.33%203.61M | 1.27%89.22M | 31.13%508.09M | 32.82%397.87M | 15.02%255.56M | -37.13%88.1M | -26.69%387.48M | -31.02%299.57M | -7.67%222.18M |
| Staff behalf paid | 7.63%211.99M | 11.99%143M | 13.06%66.2M | 21.55%286.54M | 20.79%196.95M | 24.16%127.69M | -4.13%58.55M | -5.29%235.73M | -6.93%163.06M | -8.58%102.84M |
| All taxes paid | 8.46%25.91M | 14.92%18.26M | 9.49%5.3M | 15.25%31.99M | 15.94%23.88M | 9.66%15.89M | -18.68%4.84M | -11.97%27.76M | -33.94%20.6M | -33.75%14.49M |
| Cash paid relating to other operating activities | 28.93%130.95M | 5.97%85.36M | 4.67%46.16M | 19.48%151.96M | -9.06%101.57M | 22.71%80.55M | -12.67%44.11M | -38.10%127.19M | -23.84%111.69M | -47.54%65.65M |
| Cash outflows from operating activities | -3.83%692.69M | -6.14%450.24M | 5.77%206.88M | 25.76%978.59M | 21.07%720.28M | 18.40%479.69M | -24.09%195.6M | -23.30%778.16M | -24.44%594.91M | -18.99%405.15M |
| Net cash flows from operating activities | 36.13%41.59M | 2,386.00%39.05M | -356.22%-6.14M | -68.71%38.91M | -68.22%30.55M | -88.78%1.57M | 271.59%2.39M | -14.48%124.33M | 219.46%96.15M | -38.88%14M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -76.79%793.26K | -79.45%702.48K | -98.19%62.02K | -95.46%2.46M | -92.71%3.42M | -92.71%3.42M | -92.57%3.42M | -76.26%54.18M | -69.08%46.9M | 116.44%46.9M |
| Cash received from returns on investments | 166.00%8.49M | 1,966.96%6.75M | 140.10%412.62K | 895.22%4.73M | 324.52%3.19M | -38.86%326.51K | -17.08%171.85K | 153.05%475.32K | 19.75%751.62K | 855.54%534.05K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 228.94%4.6M | -5.38%576.13K | -99.97%130 | 4.12%1.89M | 9.28%1.4M | 38.22%608.87K | 544.79%478.11K | -48.85%1.81M | 18.75%1.28M | -57.30%440.51K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.08%7M | -93.08%7M |
| Cash inflows from investing activities | 73.33%13.88M | 84.41%8.03M | -88.33%474.77K | -83.93%9.08M | -85.69%8.01M | -92.07%4.35M | -91.21%4.07M | -83.00%56.47M | -78.03%55.93M | -55.74%54.88M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -56.53%7.67M | -36.87%5.32M | -38.59%2.72M | -42.47%23.42M | -25.63%17.63M | -0.98%8.43M | -32.84%4.44M | -22.40%40.71M | -29.89%23.71M | -40.30%8.52M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | -60.00%10M | -60.00%10M | ---- | -55.61%116.37M | -84.68%25M | -42.06%25M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 208.61%50M | ---- |
| Cash outflows from investing activities | -72.26%7.67M | -71.12%5.32M | -38.59%2.72M | -85.09%23.42M | -72.01%27.63M | -45.00%18.43M | -85.97%4.44M | -52.52%157.08M | -53.69%98.71M | -54.47%33.52M |
| Net cash flows from investing activities | 131.64%6.21M | 119.20%2.7M | -512.15%-2.25M | 85.74%-14.35M | 54.12%-19.63M | -165.92%-14.08M | -102.50%-367.32K | -8,189.27%-100.62M | -203.35%-42.78M | -57.59%21.36M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -96.08%972K | ---- | ---- | 2,423.84%11.61M | 12,304.75%24.81M | ---- | ---- | -99.41%460K | -99.74%200K | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | 12,304.75%24.81M | ---- | ---- | ---- | -99.74%200K | ---- |
| Cash from borrowing | -7.00%309.98M | -18.01%251.98M | 2.79%120.11M | 89.76%399.58M | 75.43%333.31M | 53.65%307.31M | 46.06%116.85M | -18.75%210.57M | 12.43%190M | 25.79%200M |
| Cash received relating to other financing activities | -59.34%14.6M | -52.75%14.6M | ---- | -34.12%63.35M | -50.99%35.91M | 409.06%30.9M | -3.36%30.01M | 228.69%96.16M | 72.25%73.27M | -85.73%6.07M |
| Cash inflows from financing activities | -17.38%325.55M | -21.18%266.58M | -18.21%120.11M | 54.48%474.54M | 49.55%394.03M | 64.12%338.21M | 32.24%146.85M | -16.12%307.19M | -8.85%263.47M | -26.15%206.07M |
| Borrowing repayment | 21.45%289.06M | -7.50%199.26M | 10.63%110.56M | 21.42%281.72M | 23.01%238.01M | 42.33%215.41M | 30.52%99.93M | -50.32%232.02M | -40.09%193.5M | -57.00%151.35M |
| Dividend interest payment | 12.24%11.95M | 29.26%7.71M | 27.74%3.65M | 21.95%14.5M | 21.23%10.65M | -5.76%5.96M | 126.25%2.86M | -28.01%11.89M | -31.45%8.78M | -28.24%6.33M |
| Cash payments relating to other financing activities | -37.64%86.95M | -36.49%56.66M | -27.75%23.53M | 156.22%192.25M | 174.84%139.43M | 242.18%89.21M | 87.11%32.56M | -18.93%75.03M | -12.95%50.73M | 14.76%26.07M |
| Cash outflows from financing activities | -0.03%387.96M | -15.12%263.63M | 1.76%137.73M | 53.15%488.47M | 53.39%388.09M | 69.03%310.59M | 42.13%135.35M | -44.63%318.95M | -35.80%253.01M | -52.09%183.75M |
| Net cash flows from financing activities | -1,150.86%-62.41M | -89.33%2.95M | -253.21%-17.62M | -18.50%-13.93M | -43.21%5.94M | 23.76%27.62M | -27.28%11.5M | 94.40%-11.75M | 109.95%10.46M | 121.35%22.32M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -186.62%-14.61M | 195.88%44.7M | -292.22%-26.01M | -11.11%10.63M | -73.58%16.86M | -73.80%15.11M | -56.55%13.53M | 118.91%11.96M | 290.17%63.83M | 284.65%57.67M |
| Add:Begin period cash and cash equivalents | 18.65%67.61M | 18.65%67.61M | 18.65%67.61M | 26.56%56.98M | 26.56%56.98M | 26.56%56.98M | 26.56%56.98M | -58.41%45.02M | -58.41%45.02M | -58.41%45.02M |
| End period cash equivalent | -28.22%53M | 55.80%112.31M | -41.00%41.6M | 18.65%67.61M | -32.16%73.84M | -29.81%72.09M | -7.42%70.51M | 26.56%56.98M | 45.74%108.85M | 33.34%102.7M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
